Subscribe To
Pfizer layoffs 2023: what to know about the latest pfe job cuts
Pfizer (NYSE: PFE ) layoffs are a hot topic among traders on Wednesday as they pour over the details of the job cuts. The Pfizer layoffs will see the ...
October 18, 2023, 10:16 am
Scancell to speak at prestigious vaccine event
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infectious disease, said its chief executive and chie...
October 18, 2023, 3:14 am
Moderna's stock pummeled to pace the s&p 500's decliners, as it heads for yet another 5-day losing streak
Shares of Moderna Inc. MRNA, -6.07% took a 5.9% beating toward a three-year low in afternoon trading Tuesday, enough to lead the S&P 500's SPX, -0.21%...
October 17, 2023, 2:30 pm
J&j beats profit estimates on pharmaceutical, medtech sales as covid-19 shot revenue slows
Johnson & Johnson (JNJ) reported better-than-anticipated results and raised its guidance as pharmaceutical and medical equipment sales gained, even wi...
October 17, 2023, 12:05 pm
Moderna (mrna) down despite maintaining covid jab sales view
Though Moderna (MRNA) reiterated its sales guidance for COVID vaccine, it warned investors that it coul...
October 17, 2023, 12:01 pm
Moderna shares slump amid concerns about covid-19 vaccine demand
Moderna (MRNA) was the worst-performing stock in the S&P 500 on Monday as shares lost over 6% after the biotech firm said it “remains comfortable”...
October 16, 2023, 4:55 pm
Novavax positive on updated covid vaccine availability in us
Novavax said on Monday it was "encouraged" by the broad availability of its updated COVID-19 vaccine be...
October 16, 2023, 4:05 pm
Pfizer confronts ‘peak of anti-vaccination rhetoric' as shares rebound
Pfizer Inc. PFE, +5.52% on Monday sought to reassure investors that it can slash costs to repair the damage done by underwhelming COVID-19 product sal...
October 16, 2023, 11:05 am
Pfizer (pfe) cuts 2023 outlook as covid products' demand falls
Pfizer (PFE) lowers its total revenue guidance for 2023 by $9 billion as sales from its COVID products, Comirnaty v...
October 16, 2023, 10:32 am
Pfizer cuts guidance on slumping covid vaccine, treatment sales
"Pfizer (PFE) lowered its 2023 sales forecast on waning COVID vaccine demand, but analysts say cost cut...
October 16, 2023, 10:07 am
Moderna reaffirms annual covid vaccine sales forecast
Moderna on Monday reaffirmed its forecast of $6 billion to $8 billion in COVID vaccine sales for the ye...
October 16, 2023, 9:17 am
Pfizer's earnings cut was 'sort of telegraphed', says e squared's les funtleyder
Les Funtleyder, E Squared Capital Management healthcare portfolio manager, joins 'Squawk Box' to discuss Pfizer cutting full-year revenue guidance by ...
October 16, 2023, 8:52 am
Vaccine stocks—including pfizer, moderna, biontech and novavax—slide amid plummeting demand
Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral ...
October 16, 2023, 7:18 am
Is novavax stock a buy now?
Novavax's coronavirus vaccine is one of the few currently authorized in the U.S. However, the company's...
October 16, 2023, 6:34 am
Pfizer and biontech take big write-downs on covid jab stocks
Covid vaccine developer BioNTech is to take a write-down of up to €900 million on its stocks of jabs...
October 16, 2023, 6:21 am
Biontech will likely take 900 mln eur write-off on pfizer-partnered vaccines
Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947 million) in the third quarter after its partner Pf...
October 16, 2023, 3:59 am
Eu delays approval of novavax's revised covid vaccine - ft
European Union (EU) regulators have delayed the decision to give approval for Novavax's variant-tailored COVID-19 v...
October 15, 2023, 12:24 am
Gritstone bio: renewed excitement for its covid-19 vaccine
GRTS's COVID-19 vaccine may produce more durable immunity than current mRNA v...
October 14, 2023, 2:21 am
Pfizer slashes outlook: projects weak demand for covid-19 vaccine and paxlovid
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tun...
October 13, 2023, 8:31 pm
Pfizer launches $3.5 billion cost-cutting program amid declining covid vaccine sales
The pharmaceutical company warned in January it expected revenue for its Covid vaccine and Paxlovid pil...
October 13, 2023, 7:43 pm